if it proves to be a helpful medical assessment tool and its shipped to aus, Korea and US... It could do its market cap in sales pretty darn quick
All the approvals are there, just needs acceptance in mainstream medicine imo.
While wheeze isnt a 'gold standard' assessment tool, its something that has been assessed by medical staff for many many years with a stethoscope, so this will hopefully be seen as a device to make such assessment a little bit more systematic.
KSX Price at posting:
1.1¢ Sentiment: Buy Disclosure: Held